Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells

Neurochemical Research

Volumn 35, Issue 8, 2010, Pages 1259-1268

  Hohnholt, Michaela ^a   Geppert, Mark ^a   Dringen, Ralf ^a,b  

^a UNIVERSITY OF BREMEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Deferoxamine; Iron; Iron oxide nanoparticles; Oligodendrocytes; Proliferation

Indexed keywords

IRON CHELATE; IRON OXIDE; IRON SALT; LACTATE DEHYDROGENASE; NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN OLN 93; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; MEMBRANE PERMEABILITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL LINE; CELL PROLIFERATION; DEFEROXAMINE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; IRON; IRON CHELATING AGENTS; NANOPARTICLES; OLIGODENDROGLIA; QUATERNARY AMMONIUM COMPOUNDS; RATS;

EID: 77955560497     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0184-5     Document Type: Article

References (51)

1. D Galaris V Skiada A Barbouti 2008 Redox signaling and cancer: the role of "labile" iron Cancer Lett 266 21 29 10.1016/j.canlet.2008.02.038 1:CAS:528:DC%2BD1cXmsFKlu7k%3D 18374479
2. M Kruszewski 2003 Labile iron pool: the main determinant of cellular response to oxidative stress Mutat Res 531 81 92 1:CAS:528:DC%2BD3sXpt1ert78%3D 14637247
3. R Dringen GM Bishop M Koeppe, et al. 2007 The pivotal role of astrocytes in the metabolism of iron in the brain Neurochem Res 32 1884 1890 10.1007/s11064-007-9375-0 1:CAS:528:DC%2BD2sXhtV2msbbF 17551833 (Pubitemid 47497889)
4. C Brodie G Siriwardana J Lucas, et al. 1993 Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle Cancer Res 53 3968 3975 1:CAS:528:DyaK3sXmtFKqsr0%3D 8358725
5. HM Lederman A Cohen JW Lee, et al. 1984 Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation Blood 64 748 753 1:CAS:528:DyaL2cXls1emsr8%3D 6380622
6. DA Green WE Antholine SJ Wong, et al. 2001 Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase Clin Cancer Res 7 3574 3579 1:CAS:528:DC%2BD3MXptFaisLg%3D 11705879
7. CE Cooper GR Lynagh KP Hoyes, et al. 1996 The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase J Biol Chem. 271 20291 20299 10.1074/jbc.271.30.17601 1:CAS:528:DyaK28Xlt1ygtLo%3D 8702762 (Pubitemid 26250724)
8. L Thelander A Graslund M Thelander 1983 Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: possible regulation mechanism Biochem Biophys Res Commun 110 859 865 10.1016/0006-291X(83)91040-9 1:CAS:528:DyaL3sXht1WqsLw%3D 6340669
9. S Nyholm GJ Mann AG Johansson, et al. 1993 Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators J Biol Chem. 268 26200 26205 1:CAS:528:DyaK3sXmsVKkt7o%3D 8253740
10. PN Dayani MC Bishop K Black, et al. 2004 Desferoxamine (DFO)-mediated iron chelation: rationale for a novel approach to therapy for brain cancer J Neurooncol 67 367 377 10.1023/B:NEON.0000024238.21349.37 15164994 (Pubitemid 39137369)
11. DR Richardson 1997 Potential of iron chelators as effective antiproliferative agents Can J Physiol Pharmacol 75 1164 1180 10.1139/cjpp-75-10-11-1164 1:CAS:528:DyaK1cXht1am 9431440 (Pubitemid 28033934)
12. Y Yu Z Kovacevic DR Richardson 2007 Tuning cell cycle regulation with an iron key Cell Cycle. 6 1982 1994 1:CAS:528:DC%2BD2sXht1Sjt7jP 17721086
13. JR Connor SL Menzies 1996 Relationship of iron to oligodendrocytes and myelination Glia. 17 83 93 10.1002/(SICI)1098-1136(199606)17:2<83::AID- GLIA1>3.0.CO;2-7 1:STN:280:DyaK28znt1OrsQ%3D%3D 8776576 (Pubitemid 26309437)
14. SA Benkovic JR Connor 1993 Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain J Comp Neurol 338 97 113 10.1002/cne.903380108 1:CAS:528:DyaK2cXhsF2ks7k%3D 8300902 (Pubitemid 23337259)
15. MD Garrick LM Garrick 2009 Cellular iron transport Biochim Biophys Acta 1790 309 325 1:CAS:528:DC%2BD1MXlslWrsLY%3D 19344751
16. SW Hulet S Menzies JR Connor 2002 Ferritin binding in the developing mouse brain follows a pattern similar to myelination and is unaffected by the jimpy mutation Dev Neurosci 24 208 213 10.1159/000065704 1:CAS:528: DC%2BD38Xot1Ois7o%3D 12401960 (Pubitemid 36151451)
17. B Todorich JM Pasquini CI Garcia, et al. 2009 Oligodendrocytes and myelination: the role of iron Glia. 57 467 478 10.1002/glia.20784 18837051
18. N Song H Jiang J Wang, et al. 2007 Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx J Neurosci Res 35 3118 3126 10.1002/jnr.21430 (Pubitemid 350057367)
19. JR Burdo SL Menzies IA Simpson, et al. 2001 Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat J Neurosci Res 66 1198 1207 10.1002/jnr.1256 1:CAS:528:DC%2BD3MXovVCmt7s%3D 11746453 (Pubitemid 33135606)
20. B Todorich X Zhang B Slagle-Webb, et al. 2008 Tim-2 is the receptor for H-ferritin on oligodendrocytes J Neurochem 107 1495 1505 10.1111/j.1471-4159. 2008.05678.x 1:CAS:528:DC%2BD1MXis1Sksw%3D%3D 19014383
21. SW Hulet EJ Hess W Debinski, et al. 1999 Characterization and distribution of ferritin binding sites in the adult mouse brain J Neurochem 72 868 874 10.1046/j.1471-4159.1999.720868.x 1:CAS:528:DyaK1MXmt1yksQ%3D%3D 9930764 (Pubitemid 29055254)
22. C Richter-Landsberg M Heinrich 1996 OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures J Neurosci Res 45 161 173 10.1002/(SICI)1097-4547(19960715)45:2<161::AID- JNR8>3.0.CO;2-8 1:CAS:528:DyaK28XkvFWjsbs%3D 8843033 (Pubitemid 26257317)
23. M Geppert M Hohnholt L Gaetjen, et al. 2009 Accumulation of iron oxide nanoparticles by cultured brain astrocytes J Biomed Nanotechnol. 5 285 293 10.1166/jbn.2009.1033 1:CAS:528:DC%2BD1MXpsVGisrY%3D 20055010
24. J Riemer HH Hoepken H Czerwinska, et al. 2004 Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells Anal Biochem 331 370 375 10.1016/j.ab.2004.03.049 1:CAS:528:DC%2BD2cXlvVWju74%3D 15265744 (Pubitemid 38953089)
25. GM Bishop SR Robinson 2001 Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke Brain Res 907 175 187 10.1016/S0006-8993(01)02303-4 1:CAS:528:DC%2BD3MXks1Onu7w%3D 11430901 (Pubitemid 32595527)
26. T Moos K Mollgard 1993 A sensitive post-DAB enhancement technique for demonstration of iron in the central nervous system Histochemistry. 99 471 475 1:CAS:528:DyaK3sXltlCks7Y%3D 7691783
27. R Dringen L Kussmaul B Hamprecht 1998 Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay Brain Res Brain Res Protoc. 2 223 228 10.1016/S1385-299X(97)00047-0 1:CAS:528:DyaK1cXisVKgsbY%3D 9507143 (Pubitemid 28277484)
28. MM Schmidt R Dringen 2009 Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes Front Neuroenergetics. 1 1 10 19584905
29. OH Lowry NJ Rosebrough AL Farr, et al. 1951 Protein measurement with the Folin phenol reagent J Biol Chem. 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
30. HH Hoepken T Korten SR Robinson, et al. 2004 Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate J Neurochem 88 1194 1202 10.1046/j.1471-4159.2003.02236.x 1:CAS:528: DC%2BD2cXhvFOru7w%3D 15009675 (Pubitemid 38280687)
31. M Gharagozloo Z Khoshdel Z Amirghofran 2008 The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine Eur J Pharmacol 589 1 7 10.1016/j.ejphar.2008. 03.059 1:CAS:528:DC%2BD1cXptVCms7k%3D 18619590
32. H Keberle 1964 The biochemistry of desferrioxamine and its relation to iron metabolism Ann N Y Acad Sci 119 758 768 10.1111/j.1749-6632.1965.tb54077.x 1:CAS:528:DyaF2MXhs1WrtQ%3D%3D 14219455
33. DR Richardson E Baker 1994 Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake J Cell Physiol 161 160 168 10.1002/jcp.1041610119 1:CAS:528:DyaK2cXmt1Olt7k%3D 7929602 (Pubitemid 24315661)
34. JL Ware DF Paulson KS Webb 1984 1, 10-Phenanthroline reversibility inhibits proliferation of two human prostate carcinoma cell lines (PC-3 and DU145) Biochem Biophys Res Commun 124 538 543 10.1016/0006-291X(84)91587-0 1:CAS:528:DyaL2cXmt1OqsLw%3D 6208907 (Pubitemid 15188979)
35. D Szuts T Krude 2004 Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage J Cell Sci 117 4897 4908 10.1242/jcs.01374 15456844 (Pubitemid 39517507)
36. D Trinder E Morgan 1998 Mechanisms of ferric citrate uptake by human hepatoma cells Am J Physiol 275 G279 G286 1:CAS:528:DyaK1cXlsVCktb4%3D 9688655
37. L Zhu RP Glahn CK Yeung, et al. 2006 Iron uptake by Caco-2 cells from NaFeEDTA and FeSO4: Effects of ascorbic acid, pH, and a Fe(II) chelating agent J Agric Food Chem 54 7924 7928 10.1021/jf061036z 1:CAS:528:DC%2BD28XptlWitL4%3D 17002471 (Pubitemid 44649178)
38. JR Liddell HH Hoepken PJ Crack, et al. 2006 Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity J Neurosci Res 84 578 586 10.1002/jnr.20957 1:CAS:528:DC%2BD28Xotlymsr4%3D 16721761 (Pubitemid 44196698)
39. A Brand E Schonfeld I Isharel, et al. 2008 Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage J Neurochem 105 1325 1335 10.1111/j.1471-4159.2008. 05234.x 1:CAS:528:DC%2BD1cXmsVOlsLg%3D 18208540 (Pubitemid 351590796)
40. I Schroder E Johnson S de Vries 2003 Microbial ferric iron reductases FEMS Microbiol Rev 27 427 447 10.1016/S0168-6445(03)00043-3 1:CAS:528: DC%2BD3sXksVOltLw%3D 12829278 (Pubitemid 36694663)
41. K Tulpule SR Robinson GM Bishop, et al. 2010 Uptake of ferrous iron by cultured rat astrocytes J Neurosci Res 88 563 571 1:CAS:528: DC%2BC3cXkvFCrsA%3D%3D 19746426
42. ZK Attieh CK Mukhopadhyay V Seshadri, et al. 1999 Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism J Biol Chem. 274 1116 1123 10.1074/jbc.274.2.1116 1:CAS:528:DyaK1MXmtFGktw%3D%3D 9873059 (Pubitemid 29058088)
43. ME Conrad JN Umbreit EG Moore, et al. 2000 Separate pathways for cellular uptake of ferric and ferrous iron Am J Physiol Gastrointest Liver Physiol. 279 G767 G774 1:CAS:528:DC%2BD3cXnsFOqsr8%3D 11005764
44. DL Schonberg DM McTigue 2009 Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation Exp Neurol 218 64 74 10.1016/j.expneurol.2009.04.005 1:CAS:528:DC%2BD1MXnt1ersr0%3D 19374902
45. T Islam L Josephson 2009 Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles Cancer Biomark. 5 99 107 1:CAS:528:DC%2BD1MXksFWnt7k%3D 19414927
46. Y Ge Y Zhang J Xia, et al. 2009 Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro Colloids Surf B Biointerfaces. 73 294 301 10.1016/j.colsurfb.2009.05.031 1:CAS:528:DC%2BD1MXhtVSnur%2FM 19564099
47. JS Weinstein CG Varallyay E Dosa, et al. 2010 Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review J Cereb Blood Flow Metab 30 15 35 10.1038/jcbfm.2009.192 1:CAS:528:DC%2BC3cXos1Wj 19756021
48. J Xie J Wang G Niu, et al. 2010 Human serum albumin coated iron oxide nanoparticles for efficient cell labeling Chem Commun (Camb). 46 433 435 10.1039/b917195a 1:CAS:528:DC%2BD1MXhsFykurfF
49. TR Pisanic 2nd JD Blackwell VI Shubayev, et al. 2007 Nanotoxicity of iron oxide nanoparticle internalization in growing neurons Biomaterials 28 2572 2581 10.1016/j.biomaterials.2007.01.043 1:CAS:528:DC%2BD2sXis1CrsLk%3D 17320946 (Pubitemid 46367215)
50. MD Dunning A Lakatos L Loizou, et al. 2004 Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS J Neurosci 24 9799 9810 10.1523/JNEUROSCI.3126-04. 2004 1:CAS:528:DC%2BD2cXhtVWhtrfK 15525765 (Pubitemid 39463561)
51. MF Falangola SP Lee RA Nixon, et al. 2005 Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice Neurochem Res 30 201 205 10.1007/s11064-004-2442-x 1:CAS:528:DC%2BD2MXivFeltL0%3D 15895823 (Pubitemid 40569203)